Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
Author(s) -
Rossella Elisei,
Barbara Cosci,
Cristina Romei,
Valeria Bottici,
Giulia Renzini,
Eleonora Molinaro,
Laura Agate,
A Vivaldi,
Pinuccia Faviana,
Fulvio Basolo,
Paolo Miccoli,
Piero Berti,
Furio Pacini,
Aldo Pinchera
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-1714
Subject(s) - somatic cell , thyroid carcinoma , medicine , medullary cavity , lymph node , stage (stratigraphy) , germline mutation , oncology , thyroid cancer , mutation , cancer , cancer research , thyroid , pathology , biology , genetics , gene , paleontology
Medullary thyroid carcinoma (MTC) is a well-differentiated thyroid tumor that maintains the typical features of C cells. An advanced stage and the presence of lymph node metastases at diagnosis have been demonstrated to be the most important bad prognostic factors. Somatic RET mutations have been found in 40-50% of MTCs. Although a relationship between somatic mutations and bad prognosis has been described, data are controversial and have been performed in small series with short-term follow ups. The aim of this study was to verify the prognostic value of somatic RET mutations in a large series of MTCs with a long follow up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom